國立虎尾科技大學 |

Management of advanced prostate cancer

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Management of advanced prostate cancer/ edited by Choung Soo Kim.
其他作者:	Kim, Choung Soo.
出版者:	Singapore :Springer Singapore : : 2018.,
面頁冊數:	ix, 201 p. :digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Prostate - Cancer. -
電子資源:	http://dx.doi.org/10.1007/978-981-10-6943-7
ISBN:	9789811069437

Management of advanced prostate cancer
Management of advanced prostate cancer[electronic resource] /edited by Choung Soo Kim. - Singapore :Springer Singapore :2018. - ix, 201 p. :digital ;24 cm.

Section 1. Surgery for advanced prostate cancer -- Section 2 Radiotherapy for advanced prostate cancer -- Section 3. Androgen deprivation therapy for advanced prostate cancer -- Section 4. Chemotherapy and immunotherapy and palliative care for advanced prostate cancer.

This textbook summarizes the state of the art in the management of locally advanced and metastatic prostate cancer with the aim of providing the knowledge required for optimal treatment decision making in individual cases. Readers will find comprehensive coverage of the latest developments in surgery, radiotherapy, androgen deprivation therapy (ADT), chemotherapy, and immunotherapy. The role of the hormonal therapies abiraterone and enzalutamide and docetaxel-based chemotherapy in castration-resistant prostate cancer and hormone-sensitive metastatic disease is carefully evaluated. Among the other therapies discussed are LHRH agonists and antagonists, cabazitaxel, radium-223, and various novel agents still under clinical trials. The section on surgical approaches addresses, among other topics, the use of robot-assisted radical prostatectomy, pelvic lymphadenectomy, and the benefits of adjuvant and neoadjuvant therapy. The current role of external beam radiotherapy, alone or in combination with ADT and brachytherapy, for locally advanced disease is reviewed. Management of Advanced Prostate Cancer will be a valuable resource for practitioners at all levels of expertise.

ISBN: 9789811069437

Standard No.: 10.1007/978-981-10-6943-7doiSubjects--Topical Terms:

645567
Prostate
--Cancer.

LC Class. No.: RC280.P7 / M363 2018

Dewey Class. No.: 616.99463

Management of advanced prostate cancer
LDR:02376nam a2200313 a 4500 001 928049
003 DE-He213
005 20190131132832.0
006 m d
007 cr nn 008maaau
008 190626s2018 si s 0 eng d
020 $a 9789811069437 $q (electronic bk.)
020 $a 9789811069420 $q (paper)
024 7 $a 10.1007/978-981-10-6943-7 $2 doi
035 $a 978-981-10-6943-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.P7 $b M363 2018
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99463 $2 23
090 $a RC280.P7 $b M266 2018
245 0 0 $a Management of advanced prostate cancer $h [electronic resource] / $c edited by Choung Soo Kim.
260 $a Singapore : $c 2018. $b Springer Singapore : $b Imprint: Springer,
300 $a ix, 201 p. : $b digital ; $c 24 cm.
505 0 $a Section 1. Surgery for advanced prostate cancer -- Section 2 Radiotherapy for advanced prostate cancer -- Section 3. Androgen deprivation therapy for advanced prostate cancer -- Section 4. Chemotherapy and immunotherapy and palliative care for advanced prostate cancer.
520 $a This textbook summarizes the state of the art in the management of locally advanced and metastatic prostate cancer with the aim of providing the knowledge required for optimal treatment decision making in individual cases. Readers will find comprehensive coverage of the latest developments in surgery, radiotherapy, androgen deprivation therapy (ADT), chemotherapy, and immunotherapy. The role of the hormonal therapies abiraterone and enzalutamide and docetaxel-based chemotherapy in castration-resistant prostate cancer and hormone-sensitive metastatic disease is carefully evaluated. Among the other therapies discussed are LHRH agonists and antagonists, cabazitaxel, radium-223, and various novel agents still under clinical trials. The section on surgical approaches addresses, among other topics, the use of robot-assisted radical prostatectomy, pelvic lymphadenectomy, and the benefits of adjuvant and neoadjuvant therapy. The current role of external beam radiotherapy, alone or in combination with ADT and brachytherapy, for locally advanced disease is reviewed. Management of Advanced Prostate Cancer will be a valuable resource for practitioners at all levels of expertise.
650 0 $a Prostate $x Cancer. $3 645567
650 1 4 $a Medicine & Public Health. $3 593949
650 2 4 $a Oncology. $3 593951
650 2 4 $a Urology. $3 645258
650 2 4 $a Surgical Oncology. $3 673742
700 1 $a Kim, Choung Soo. $3 1207781
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-6943-7
950 $a Medicine (Springer-11650)